Filed Pursuant to Rule 424(b)(4)
Registration No. 333-252785
PROSPECTUS
$200,000,000
SVF Investment Corp. 2
20,000,000 Class A Ordinary Shares
SVF Investment Corp. 2 is a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which we refer to as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We will not be limited to a particular industry or geographic region in our identification and acquisition of a target company.
This is an initial public offering of our securities. Each Class A ordinary shares has an offering price of $10.00. The underwriters have a 45-day option from the date of this prospectus to purchase up to 3,000,000 additional Class A ordinary shares to cover over-allotments, if any.
We will provide our public shareholders with the opportunity to redeem all or a portion of their Class A ordinary shares upon the completion of our initial business combination, subject to the limitations as described herein. If we have not consummated an initial business combination within 24 months from the closing of this offering, we will redeem 100% of the public shares for cash, subject to applicable law and certain conditions as described herein.
Our sponsor, SVF Sponsor II (DE) LLC, an affiliate and wholly-owned subsidiary of SB Investment Advisers (US) Inc., has agreed to purchase 700,000 Class A ordinary shares ( or 760,000 Class A ordinary shares if the underwriters’ over-allotment option is exercised in full) at a price of $10.00 per share, in a private placement to occur concurrently with the closing of this offering.
SVF II SPAC Investment 2 (DE) LLC, an affiliate of our sponsor, have entered into a forward purchase agreement with us that provides for the purchase of $100,000,000 committed forward purchase shares, for $10.00 per share, in a private placement to close substantially concurrently with the closing of our initial business combination. The forward purchase agreement also provides that the forward purchase investors may elect to purchase up to an additional $50,000,000 of forward purchase shares, for a purchase price of $10.00 per share. Any elections to purchase up to 5,000,000 additional forward purchase shares will take place in one or more private placements in such amounts and at such time as the forward purchase investors determine, but no later than simultaneously with the closing of our initial business combination. We and the forward purchase investor may determine, by mutual agreement, to increase the number of additional forward purchase shares at any time prior to our initial business combination. The obligations under the forward purchase agreement will not depend on whether any Class A ordinary shares are redeemed by our public shareholders. The terms of the forward purchase shares will generally be identical to the terms of Class A ordinary shares being sold in this offering, except that they will have certain registration rights and be subject to certain transfer restrictions, as described herein.
Our initial shareholder, being the sponsor, currently owns 5,750,000 Class B ordinary shares, up to 750,000 of which are subject to forfeiture depending on the extent to which the underwriters’ over-allotment option is exercised. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of our initial business combination or earlier at the option of the holders thereof as described herein.
Certain of our directors and officers have indicated an interest in purchasing up to 300,000 Class A ordinary shares in the aggregate in this offering.
Prior to our initial business combination, only holders of our Class B ordinary shares will be entitled to vote on the appointment of directors.
Prior to this offering, there is no public market for our securities. We have been approved to list our Class A ordinary shares on NASDAQ, under the symbol “SVFB.”
We are an “emerging growth company” under applicable federal securities laws and will be subject to reduced public company reporting requirements.
Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page 31 for a discussion of information that should be considered in connection with an investment in our securities. Investors will not be entitled to protections normally afforded to investors in Rule 419 blank check offerings.
Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
| | | | | | | | |
| | Per Share | | | Total | |
Public offering price | | $ | 10.00 | | | $ | 200,000,000 | |
Underwriting discounts and commissions(1) | | $ | 0.55 | | | $ | 11,000,000 | |
Proceeds, before expenses, to us | | $ | 9.45 | | | $ | 189,000,000 | |
(1) | Includes $0.35 per share, or $7,000,000 in the aggregate (or $8,050,000 in the aggregate if the underwriters’ over-allotment option is exercised in full), payable to the underwriters for deferred underwriting commissions to be placed in a trust account located in the United States as described herein and released to the underwriters only upon the consummation of an initial business combination. See also “Underwriting” for a description of compensation payable to the underwriters. |
Of the proceeds we receive from this offering and the sale of the private placement shares described in this prospectus, $200,000,000, or $230,000,000 if the underwriters’ over-allotment option is exercised in full ($10.00 per share in either case), will be deposited into a U.S. based trust account with Continental Stock Transfer & Trust Company acting as trustee.
The underwriters are offering the shares for sale on a firm commitment basis. The underwriters expect to deliver the shares to the purchasers on or about March 11, 2021.
Joint Book-Running Managers
| | | | | | | | |
Citigroup | | UBS Investment Bank | | Deutsche Bank Securities | | Cantor | | Mizuho Securities |
The date of this prospectus is March 8, 2021